companiesandmarkets.com

Return to Report | Print

Biovail Corporation - Corporate and Strategic Assessment Report - Company Strategy, SWOT Analysis

http://www.companiesandmarkets.com/Summary-Company-Profile/biovail-corporation-corporate-and-strategic-assessment-report-company-strategy,-swot-analysis-46009.asp

Report Summary

Introduction

Biovail is a specialty pharmaceutical company engaged in the formulation, clinical testing, registration, manufacture and commercialization of pharmaceutical products, utilizing advanced drug-delivery technologies. The company currently has over 20 distinct, proprietary drug-delivery technologies, and has access to other technologies through licensing agreements with development partners.

Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


    • Highlights

    Biovail's branded products in Canada include: Tiazac XC, Wellbutrin XL, Glumetza, Lescol, Lescol XL and Zyban. The company's wholly-owned US subsidiary includes administrative, product distribution and related regulatory affairs functions. Its products include Cardizem CD, Ativan, Vaseretic, Vasotec, and Isordil.

    Biovail derives its revenues primarily from the sales of pharmaceutical products developed and manufactured by the company, as well as sales of proprietary and in-license products;pharmaceutical clinical research and laboratory testing services, and product development activities in collaboration with third parties;

    The company's total revenues increased at a CAGR of 7.9% during 2002-2006, from $788 million to $1,067.7 million. This represents an absolute total growth of +$279.7 million for total revenues. The increase is primarily attributable to increased product sales.

    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization

    • Table of Contents

    TABLE OF CONTENTS
    Overview 1
    Catalyst 1
    Summary 1
    Company Structure 6
    Company Overview and Key Facts 6
    Business Description 7
    History 10
    Locations and Subsidiaries 14
    Company Financials 15
    Stock Market Performance 15
    P&L 16
    Balance Sheet 21
    Cash Flow 21
    Geographic Segment Performance 22
    Products & Services 23
    Marketed Products 23
    Pipeline Products 26
    Historical Product Sales 28
    AC Forecast Product Sales 29
    Competitors and Strategic Business Relationships 31
    Key Competitors 31
    Key Suppliers 32
    Key Clients 33
    Strategy 34
    Company View 34
    Corporate Strategy 38
    SWOT Analysis 39
    Overview 39
    Strengths 40
    Weaknesses 41
    Opportunities 42
    Threats 43
    Value Chain Analysis 44
    Overview 44
    Discovery and Product Development 45
    Manufacturing 45
    Sales 45
    Scorecard 46
    Overview 46
    Scorecard Analysis 47
    Key Employees 48
    List of Key Employees 48
    Key Employee Biographies 49
    Financial and Operational Overview 54
    Financial and Operational Overview 54
    APPENDIX 56
    Ask the analyst 56
    Datamonitor consulting 56
    Disclaimer 56


    TABLE OF FIGURES
    Figure 1: Biovail - Key Strategic Revenues, 2002-2006 ($ Mn) 17
    Figure 2: Biovail - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 18
    Figure 3: Biovail - Key Strategic Revenues, 2006-2010 ($ Mn) 30


    TABLE OF TABLES
    Table 1: Biovail - Key Facts 6
    Table 2: Biovail – Locations and Subsidiaries 14
    Table 3: Biovail - Year-End Share Price and Market Capitalization, 2002-2006 ($) 15
    Table 4: Biovail - Key Events Impacting Share Price Performance 15
    Table 5: Biovail - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 16
    Table 6: Biovail - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues) 20
    Table 7: Biovail - Balance Sheet, 2002-2006 ($ Mn) 21
    Table 8: Biovail – Cash Flow, 2002-2006 ($ Mn) 21
    Table 9: Biovail - Geographic Breakdown, 2002-2006 ($ Mn) 22
    Table 10: Biovail - Marketed Products 23
    Table 11: Biovail - In-house Pipeline Products 26
    Table 12: Biovail - Historical Product Sales, 2002-2006 ($ Mn) 28
    Table 13: Biovail - Forecast Sales, 2006-2010 ($ Mn) 29
    Table 14: Biovail - Key Competitors 31
    Table 15: Biovail - Key Suppliers 32
    Table 16: Biovail - Key Clients 33
    Table 17: Biovail - SWOT Analysis Summary 39
    Table 18: Biovail - Value Chain Analysis 44
    Table 19: Biovail - Scorecard 46
    Table 20: Biovail - Key Employees 48
    Table 21: Biovail - Financial and Operational Overview 54